12 Saphenous Vein Grafts for High-Flow Cerebral Revascularization
Indications for high-flow revascularization
Intracranial and extracranial occlusive vascular disease, can lead to progressive compromise of cerebral blood flow that may necessitate augmentation of cerebral blood flow. Trauma may result in loss or compromise of a major arterial supply to the brain and hence a need for revascularization. Further, as a greater number of complex aneurysm recurrences are seen after endovascular treatment, revascularization strategies have increased in importance. Treating these complex vascular lesions may require complex clip reconstruction techniques requiring extended temporary artery occlusion times or parent artery sacrifice. Lesions located on the M1 and P1 segments may require prophylactic bypass due to the frequent presence of perforating vessels and low tolerance of temporary occlusion in these territories. Further, many vascular lesions involve extensive atherosclerotic changes in the neck, very broad based, or giant in size, thus potentially necessitating branch or parent artery sacrifice. Finally, previously endovascularly treated vascular lesions may require complex vascular reconstructions at retreatment, that is, removal of coil mass, potentially demanding, long parent artery occlusion times. The choice of the anastomosis site is selected based on the location of the lesion, intended territory of revascularization, and properties of the donor and recipient vessels. BTO can facilitate decision making in most cases (Table 12–1). After temporary occlusion of a parent artery, the global cerebral hemodynamics are examined, with particular attention to the vascular reserve provided by the leptomeningial and circle of Willis vessels and subsequently the flow dynamics including venous washout are carefully studied.
Cerebral Blood Flow Needed | Balloon Trial Occlusion Results |
---|---|
No bypass | No clinical deficits or SPECT abnormalities |
Low-flow bypass | Clinical deficits during hypotensive state with/without EEG changes; no SPECT abnormalities |
High-flow bypass | Clinical deficits with SPECT abnormalities |
EEG, electroencephalogram; SPECT, single-photon emission computed tomography.
Saphenous vein considerations
The saphenous vein graft has been used for decades for bypass procedures with relatively great success. Lougheed is credited for performing the first intracranial bypass using a saphenous vein graft in 1971.1 Despite an overall decrease in the use of intracranial SV bypasses due to an increased use of endovascular techniques for complex intracranial vascular disease and an increased experience and usage of radial artery grafts, the SV graft still provides a highly flexible and adaptable bypass graft for a variety of uses, including a primary conduit from the carotid artery or superficial temporal artery or as an interposition graft. The saphenous vein has a measured flow rate between 70 and 200 ml/min and an average diameter of ∼5 mm.2,3 The advantages of the SV graft are the ease of harvest, autologous source, length of graft able to be obtained, absence of atherosclerotic changes throughout the length of the vessel, absence of vasospasm, and large caliber of graft able to be harvested. Several disadvantages of SV grafts exist and are most commonly frequent caliber mismatch between donor and recipient vessels, which can often lead to intraluminal turbulent flow and eventual thrombosis, the presence of valves that can be sites of thrombus formation, greater possibility of reperfusion hemorrhage, and the potential for kinking at the site of the recipient due to the thick surrounding tissue and vessel wall. Saphenous vein bypass grafts require two separate anastomosis sites and separate incisions for graft harvest, which increases the potential for complications. Although long-term patency rates have not been directly compared between RA and SV grafts, the average patency rate at 5 years postimplantation has been reported to be ∼90% for RA grafts and ∼80% for SV grafts. In the coronary literature, RAs have been consistently reported to have higher patency rates compared to SVs.2–4
Patients undergoing revascularization procedures are usually placed on aspirin therapy before or immediately after the revascularization procedure. In cases of hypercholesterolemia, a statin can be administered pre- and post-operatively, which has been suggested to positively affect long-term graft patency.2,3,5